Early (6 months) results of a pilot prospective study to investigate the efficacy and safety of sirolimus coated balloon angioplasty for dysfunctional arterio-venous …

TY Tang, SXY Soon, CJQ Yap, SL Chan, RY Tan… - PLoS …, 2020 - journals.plos.org
Background The aim of this pilot study was to evaluate the safety and efficacy of the
MagicTouch™ sirolimus-coated balloon (SCB) catheter (Concept Medical Inc., Tampa, FL …

Endovascular salvage of failing arterio-venous fistulas utilising sirolimus eluting balloons: Six months results from the ISABELLA trial

TY Tang, SXY Soon, CJQ Yap, RY Tan… - The Journal of …, 2023 - journals.sagepub.com
Background: Aim of this pilot clinical study was to evaluate the safety and efficacy of the
Selution Sustained Limus Release (SLR)™ sirolimus-eluting balloon (SEB) for improving …

Recurrent stenoses in arteriovenous fistula (AVF) for dialysis access: cuttIng ballooN angioplaSTy combined wITh paclitaxel drUg-coaTed balloon angioplasty, an …

Z Tan, SXJM Chan, K Da Zhuang, T Urlings… - CardioVascular and …, 2022 - Springer
Purpose To study the safety and efficacy of cutting balloon angioplasty (CBA) followed by
paclitaxel drug-coated balloon (PCB) angioplasty for recurrent venous lesions in …

Efficacy and safety of paclitaxel-coated balloon angioplasty for dysfunctional arteriovenous fistulas: a multicenter randomized controlled trial

Y Yin, Y Shi, T Cui, H Li, J Chen, L Zhang, Z Yu… - American Journal of …, 2021 - Elsevier
Rationale & Objective Previous studies have illustrated the potential superiority of drug-
coated balloons (DCBs) in maintaining patency after initial angioplasty for arteriovenous …

Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized …

C Luo, M Liang, Y Liu, D Zheng, Q He, J Jin - Renal Failure, 2022 - Taylor & Francis
Purpose To compare the efficacy and safety between paclitaxel coated balloon (PCB)
angioplasty and conventional balloon (CB) angioplasty in the treatment of dysfunctional …

The efficacy of paclitaxel drug-eluting balloon angioplasty versus standard balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: an analysis of …

I Yildiz - Cardiovascular and interventional radiology, 2019 - Springer
Purpose To investigate the efficacy of paclitaxel drug-eluting balloons (PEB) versus
standard balloon angioplasty (BA) in stenosis of native hemodialysis arteriovenous fistulas …

[HTML][HTML] Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas

RA Lookstein, H Haruguchi, K Ouriel… - … England Journal of …, 2020 - Mass Medical Soc
Background Standard percutaneous transluminal angioplasty is the current recommended
treatment for dysfunctional hemodialysis fistulas, yet long-term outcomes of this treatment …

Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized …

K Katsanos, D Karnabatidis, P Kitrou… - Journal of …, 2012 - journals.sagepub.com
Purpose To report the 6-month results of a prospective randomized trial investigating
angioplasty with paclitaxel-coated balloons (PCB) vs. plain balloon angioplasty (BA) for the …

[PDF][PDF] Drug-coated balloon angioplasty for dysfunctional arteriovenous hemodialysis fistulae: a randomized controlled trial

Y Zhao, P Wang, Y Wang, L Zhang, H Li… - Clinical Journal of the …, 2023 - journals.lww.com
Background: This study aims to evaluate the efficacy and safety of paclitaxel-coated
balloons (Acoart Orchid) in treating dysfunctional arteriovenous fistulae. Methods: The drug …

Multicenter randomized controlled trial to assess the effectiveness of PASSEO-LUX DCB® drug coated balloon compared to plain balloon angioplasty of …

T Moreno-Sánchez… - The Journal of …, 2024 - journals.sagepub.com
Purpose: To compare primary patency after angioplasty with drug-coated balloon (DCB)-
Passeo-18Lux, BIOTRONIK versus uncoated balloon in dysfunctional peripheral vascular …